Skip to main content

Global Tinea Corporis Market Size is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023

Tinea corporis is contagious infection which can spread from one person to other hence it is important not to share towel, flannels, bathmats with another person. Tinea corporis is a fungal infection that is caused by tinea rubrum, trichophyton mentagrophytes and epidermophyton floccosum fungi.
This fungal infection mainly occurs in humid climatic condition. It is also known as ringworm infection. Tinea corporis infection occurs mostly on arms, legs or can also occur on different parts of body. The global Tinea Corporis Market Size is expected to see the growth in upcoming year due to entry of new drug product in market for treatment. Many key players in market are engaged in development of new drug product for tinea corporis treatment.
Global Tinea Corporis Market Size is expected to rise steadily at a CAGR of 7.2% during forecast period of 2018-2023.
Market Segmentation:
Global Tinea Corporis Market Size is segmented into drug type, diagnosis, treatment and end-users. Tinea Corporis Market Size on basis of drug types is segmented into antifungals, steroids and anti-infective combinations.
Global Tinea Corporis Market Size by Drug Type
  • Antifungals
  • Steroids
  • Anti-Infective Combinations
Global Tinea Corporis Market Size, by Diagnosis
  • Physical Exam

  • Imaging Tests
    Wood lamp (black light) examination
    Microscopy using potassium hydroxide (KOH)
    Fungal culture
    Skin biopsy
    Others
Global Tinea Corporis Market Size, by Treatment
  • Antifungal shampoos
  • Antifungal creams
  • Drugs
  • Others
Global Tinea Corporis Market Size, by End-Users
  • Hospital Pharmacies
  • Drug Stores
  • Online Pharmacies
  • Dermatology hospitals
  • Others
Top Industry Key players:
Some of the key players in the global Tinea Corporis Market Size are –
  • Teva Pharmaceuticals Inc.
  • Glenmark Pharmaceuticals Inc
  • NorthStar Rx LLC
  • Aurobindo Pharma Limited
  • Camber Pharmaceuticals Inc.
  • AvKare Inc.
  • Novartis AG
  • Sebela Pharmaceuticals Inc.
  • Bayer AG
  • Blueberry Therapeutics Ltd
  • Perrigo Company
  • Taro Pharmaceuticals. Inc.
  • Breckenridge Pharmaceutical Inc.
LIST OF TABLES
Table 1 Global Tinea Corporis Market Size Synopsis, 2018–2023
Table 2 Global Tinea Corporis Market Size Estimates and Forecast, 2018–2023 (USD Million)
Table 3 Global Tinea Corporis Market Size, By Region, 2018–2023 (USD Million)
Table 4 Global Tinea Corporis Market Size, By Drug Type, 2018–2023 (USD Million)
Table 5 Global Tinea Corporis Market Size, By Diagnosis, 2018–2023 (USD Million)
Table 6 Global Tinea Corporis Market Size, By Treatment, 2018–2023 (USD Million)
Table 7 Global Tinea Corporis Market Size, By End-Users, 2018–2023 (USD Million0
…Continues.
Browse Complete Premium Research Report Enabled with TOC at https://www.marketresearchfuture.com/reports/tinea-corporis-market-6838
Regional Market Summary
Geographically, the America holds the highest market share for Tinea Corporis Market Size and the reason being many market players are engaged in development of new drug product innovation, and as this infection is more prone to humid climatic condition there is an increasing prevalence of fungal infection in this region. Whereas increasing awareness of fungal disease and rising healthcare expenditure by the government are some of the factors responsible for growth of market in this region
Europe is expected to be the second largest market in the globe owing to the increasing aging population, increasing prevalence of fungal infection, focus on aesthetic appearance, increasing research base. Whereas rise in susceptible immune compromised patient population is responsible for market growth in this region.
Asia-Pacific is anticipated to be the fastest growing market owing to the growing prevalence of fungal infection, changing lifestyle, increase in population, increasing healthcare expenditure by government are some of the factor responsible for market growth in this region.
Intended Audience
  • Manufacturers and Suppliers
  • Hospitals and Clinics
  • Laboratories and Associations
  • Research Institutes
  • Dermatology Clinics
About Market Research Future: we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.
Contact:
Market Research Future
+1 646 845 9312
Labels:

Comments

Post a Comment

Popular posts from this blog

Transfer Membrane Market Trends, Regional Scope and Growth in Emerging Economies

  Transfer Membrane Research Report: by Type (nitrocellulose transfer membranes, PVDF transfer membranes), by Transfer Method (semi-dry electrotransfers), by Application (western blotting, southern blotting), and by End user - Global Forecast Till 2023 Market Highlights The global transfer membrane anticipated to have held a market value of USD 184.5 million in the year 2017 and is expected to grow at a CAGR of 5.3% during the forecast period. Due to increasing R&D spending by pharmaceutical and biotechnology companies, moreover increasing applications. Companies are using a trend of strategic alliance and acquisition to gain the market and minimize the competition in the market. Intended Audience Biotechnology Companies Research and Development Organization Healthcare Organizations Various research and consulting firms Avail a Free Sample@  https://www.marketresearchfuture.com/sample_request/7389 Additionally, the growing research and development expenditure by the government as w
Post a Comment
Read more

Big Data In Healthcare Market Top Companies Growth Overview BY Industry Size and Major Segments

Global Big Data In Healthcare Market is anticipated to reflect a positive growth trend in the forthcoming years and reach a significant valuation by the end 2027, reveals Market Research Future (MRFR) in a minutely analyzed research report. Big data in healthcare is gaining prominence as it can be used in the prediction of outcome of diseases prevention, reduce the cost of treatment, and prevent epidemics and in disease development. With the help of big data in predictive analysis, medical issues can be identified and addressed before it becoming an unmanageable problem. Global  Big Data In Healthcare Market  Insights 2020 provides a unique tool for evaluating the Market, highlighting opportunities, and supporting strategic and tactical decision-making. This report recognizes that in this rapidly-evolving and competitive environment, up-to-date Marketing information is essential to monitor performance and make critical decisions for growth and profitability. It provides informati
1 comment
Read more

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size, Product Scope, Technological Growth and Future Trend 2023

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size Information By Treatment (Intravenous Immunoglobulin, Corticosteroids, Plasmapheresis (Plasma Exchange), Physiotherapy, Others), Diagnosis (Electrodiagnostic Testing, Nerve Conduction, EMG, Spinal Fluid Analysis, Others), By Route of Administration (Intravenous, Oral, Others), By End User (Hospitals, Specialty Neurological Clinics, Research & Academic Laboratories, Others) and Top Regions Forecast till 2023. The “ Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size ” In-Depth competition analysis of the major companies in the report, sector of the report includes the market depictions, requirements, and product portrayals, manufacture, competence, contact figures, cost, and revenue. Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Market Size Research Coverage: Changing market dynamics of the industry To get a comprehensive overview of the Chronic Inflammatory Demyelinating Po
Post a Comment
Read more